The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 Targeted Therapy Drugs for AML - CPX-351, FLT3, IDH Inhibitors, BCL-2, & Hedgehog Pathway Inhibitor

245 views
August 19, 2019
0 Comments
Login to view comments. Click here to Login
Hematologic Malignancies